SCHEMBL1004508

SCHEMBL1004508

CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(OC)cccc3nc2-1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TOP1 P11387 18/20 1.00
▸ ALDH1A1 P00352 3/20 0.80
▸ GLA P06280 3/20 0.80
▸ RECQL P46063 2/20 0.80
▸ TDP1 Q9NUW8 2/20 0.80
▸ MEN1 O00255 2/20 0.80
▸ KMT2A Q03164 2/20 0.80
▸ SMN1; SMN2 Q16637 2/20 0.80
▸ KDM4E B2RXH2 3/20 0.79
▸ RAB9A P51151 2/20 0.79
▸ BLM P54132 2/20 0.79
▸ POLB P06746 1/20 0.79
▸ MAPT P10636 1/20 0.79
▸ ABCC4 O15439 2/20 0.74
▸ HTT P42858 2/20 0.74
▸ ABCC3 O15438 1/20 0.74
▸ ACHE P22303 1/20 0.74
▸ PTGS1 P23219 1/20 0.74
▸ ABCC2 Q92887 1/20 0.74
▸ TP53 P04637 2/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29994151 1.00 TOP1 (1.00) TOP1ALDH1A1GLARECQLTDP1
SCHEMBL27827045 1.00 TOP1 (1.00) TOP1ALDH1A1GLARECQLTDP1
Hydrochloric Acid SCHEMBL28012447 0.98 TOP1 (0.97) TOP1ALDH1A1GLARECQLTDP1
SCHEMBL17897650 0.92 TOP1 (0.85) TOP1ALDH1A1GLARECQLTDP1
SCHEMBL25932513 0.92 TOP1 (0.85) TOP1ALDH1A1GLARECQLTDP1
SCHEMBL10636628 0.91 TOP1 (0.84) TOP1ALDH1A1GLARECQLTDP1
SCHEMBL1006662 0.90 TOP1 (1.00) TOP1ALDH1A1GLARECQLTDP1
SCHEMBL27561956 0.90 TOP1 (1.00) TOP1ALDH1A1GLARECQLTDP1
SCHEMBL27367949 0.89 TOP1 (0.81) TOP1ALDH1A1GLARECQLTDP1
SCHEMBL23270615 0.89 TOP1 (1.00) TOP1ALDH1A1GLARECQLTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 373 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026086871-A1 ANTI-AGEING COMPOUNDS, USES THEREFOR, METHOD FOR IDENTIFYING, AND COMPOSITIONS CONTAINING Centre for Translational Stem Cell Biology Limited (CN) 2026-04-30 — — WO claimed
CN-117343944-A Gene, protein, recombinant vector and method for catalyzing synthesis of 9-methoxy camptothecine 上海师范大学 2024-01-05 — — CN claimed
CN-113880872-A Preparation of camptothecin boric acid compound and application of camptothecin boric acid compound in anti-tumor aspect 兰州大学 2022-01-04 — — CN claimed
CN-113880855-A Preparation of 9-fluoro camptothecin derivative and application of 9-fluoro camptothecin derivative in anti-tumor aspect 兰州大学 2022-01-04 — — CN claimed
CN-104619322-B Anticancer pharmaceutical composition and its production and use 张苑金 2016-10-19 — — CN claimed
CN-104619322-A ANTICANCER PHARMACEUTICAL COMPOSITION, PREPARATION METHOD FOR SAME, AND USE THEREOF ZHANG YUANJIN 2015-05-13 — — CN claimed
CN-102895229-A Medical application of camptothecin and its derivative in resisting Alzheimer disease UNIV CHINA PHARMA 2013-01-30 — — CN claimed
US-7994186-B2 Pharmaceutical compositions containing camptothecins KABUSHIKI KAISHA YAKULT HONSHA (JP) 2011-08-09 — — US claimed
CN-102080112-A Method for synthesizing 9-methoxy camptothecin by artificially inducing icacinaceae endophyte YUANJIN ZHANG 2011-06-01 — — CN claimed
CN-102051393-A Method for extracting camptothecin and 9-methoxyl camptothecin from root-bark of pittosporumlike nothapodytes ENSHI JINHUA BIO ENGINEERING CO LTD 2011-05-11 — — CN claimed
US-6534080-B2 Injecting into a patientaqueous suspension of solid particles suitable for intravenous delivery, the solid particles comprising a camptothecin, and a 0.3 nm to 3.0 mu m thick layer of a membrane-forming amphipathic lipid SUPER GEN, INC. 2003-03-18 — — US claimed
US-6509027-B2 Anticancer agent SUPERGEN, INC. 2003-01-21 — — US claimed
EP-1270579-A1 PROCESS FOR PRODUCING CAMPTOTHECIN Kabushiki Kaisha Yakult Honsha (JP) 2003-01-02 — — EP claimed
US-6497896-B2 AQUEOUS SUSPENSION; THERMAL STERILIZATION SUPERGEN, INC. 2002-12-24 — — US claimed
US-20020150615-A1 Injectable pharmaceutical composition comprising microdroplets of a camptothecin SKYEPHARMA AG (CH) 2002-10-17 — — US claimed
US-20020146460-A1 Method for administering camptothecins VIA injection of pharmaceutical composition comprising coated particles of a camptothecin ASTEX PHARMACEUTICALS, INC. 2002-10-10 — — US claimed
US-20020147202-A1 Method for administering camptothecins via injection of a pharmaceutical composition comprising microdroplets containing a camptothecin RTP PHARMA INC. (CA) 2002-10-10 — — US claimed
US-20020142048-A1 Injectable pharmaceutical composition comprising coated particles of camptothecin ASTEX PHARMACEUTICALS, INC. 2002-10-03 — — US claimed
WO-2002064064-A1 INJECTABLE PHARMACEUTICAL COMPOSITION COMPRISING MICROPARTICLES OR MICRODROPLETS OF CAMPTOTHECIN SUPERGEN, INC. (US) 2002-08-22 — — WO claimed
WO-2002000168-A2 COMBINATION HIV THERAPY INCLUDING CAMPTOTHECIN SUPERGEN, INC. (US) 2002-01-03 — — WO claimed
Send feedback